- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 487/14
Total number of patents in this class: 1759
10-year publication summary
|
97
|
109
|
119
|
124
|
125
|
149
|
147
|
120
|
116
|
89
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbvie Inc. | 1809 |
75 |
| Intra-Cellular Therapies, Inc. | 444 |
44 |
| Pharmacosmos Holding A/S | 203 |
39 |
| Pharmacosmos A/S | 64 |
38 |
| Merck Patent GmbH | 5772 |
33 |
| Novartis AG | 10162 |
30 |
| Idemitsu Kosan Co., Ltd. | 4291 |
26 |
| Agenebio, Inc. | 44 |
26 |
| Achillion Pharmaceuticals, Inc. | 154 |
23 |
| Prelude Therapeutics, Incorporated | 152 |
23 |
| Genentech, Inc. | 4167 |
21 |
| Dana-Farber Cancer Institute, Inc. | 2687 |
20 |
| Bristol-myers Squibb Company | 4758 |
18 |
| Bayer Pharma AG | 1001 |
18 |
| Samsung Display Co., Ltd. | 39441 |
17 |
| Duk San Neolux Co., Ltd. | 705 |
16 |
| Merck Sharp & Dohme LLC | 3715 |
15 |
| Bayer AG | 3593 |
14 |
| G1 Therapeutics, Inc. | 39 |
14 |
| Incyte Corporation | 1067 |
14 |
| Other owners | 1235 |